Is Alcohol Good, Bad, or Neutral for Cardiovascular Health?

In the 2018 Guidelines on Hypertension, commandment no. 6 states that we should make lifestyle interventions such as sodium restriction, healthy eating, regular exercise, weight control, and smoking cessation, and also alcohol moderation.

¿El alcohol es bueno, malo o neutro para la salud cardiovascular?It is clear that heavy alcohol consumption induces hypertension and may probably be one of the main causes of secondary hypertension, but few sources detail what a moderate or “healthy” consumption is.

There are consistent observational data to indicate that there is an association between alcohol use and cardiovascular events, and that, as a whole, it is U-shaped. In other words, low or moderate alcohol consumption (up to one drink or 12.5 g alcohol per day in women and up to two drinks or 25 g per day in men) are associated with a reduced risk of overall cardiovascular events and mortality, compared with absolute abstinence or excessive consumption.


Read also: Progress of patients with hypertrophic cardiomyopathy treated with alcohol septal ablation.


The alcohol content of a beverage is expressed in degrees and it measures the content of absolute alcohol in 100 cm3, i.e. the alcohol percentage in a beverage. For example, if we have a 13-degree wine, that means that it contains 13 cm3 of absolute alcohol for every 100 cm3 of wine. In product labels, alcoholic content is expressed as (°) or vol%. The calculation would be as follows: consumed volume (in cm3) × alcohol content × 0.8, and then divide all by 100. We must ask the patient about the type of beverage (so as to get the alcohol content) and the amount consumed (so as to get the volume, in cm3) in order to calculate whether such consumption is good or bad for their health.

In any case, this generalization masks important aspects that merit closer examination.

Patterns of drinking, the type of alcohol consumed, and factors associated with alcohol consumption, such as socio-economic status and dietary patterns, may modify significantly such generalization. Well-established cardiac disease also implies differences, particularly for patients with left ventricular dysfunction.


Read also: Alcohol dilemma: Cardiovascular enjoyment and benefits versus cancer.


Furthermore, the effects of alcohol on coronary pathologies may differ from its effects on arrhythmias or heart failure risk, and they may also differ on ischaemic stroke and intracerebral haemorrhage.

It is important to consider that even if there is a modest cardiovascular benefit derived from moderate consumption, it may imply a risk of cancer and cirrhosis.

Finally, the data supporting this modest benefit have emerged from observational studies that are subject to many methodological limitations and potential confounding variables.


Read also: MitraClip in the “Real World”.


Consequently, for the time being, it may be better to advise restraint as opposed to support consumption to reduce cardiovascular risk.

leong2019-libre-para-publicar

Original title: Are the Cardiac Effects of Alcohol Good, Bad, or Neither?

Reference: Leong DP et al. Eur Heart J. 2019 Mar 1;40(9):712-714.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

STEACS and the Use of Bivalirudin vs. Heparin: In Search of BRIGHT-4 Outcomes

Various studies and registries have previously shown the impact of post-percutaneous coronary intervention (PCI) complications on the survival of patients with ST-segment elevation acute...

TAVR and Atrial Fibrillation: What Anticoagulants Should We Use?

The prevalence of atrial fibrillation (AF) in TAVR patients ranges from 15 to 30%, depending on series. This arrhythmia has been associated to higher...

Ultrathin vs Thin-Strut Stents in PCI Patients at High Bleeding Risk

Several in vivo studies have shown that ultrathin stents present lower thrombogenic risk vs. thin-strut stents, which reflects in lower rates of target lesion...

Should We Withdraw Anticoagulation Before TAVR?

Approximately one-third of patients undergoing transcatheter aortic valve replacement (TAVR) have atrial fibrillation and are on oral anticoagulant (OAC) therapy. This creates a complex...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....